Financial Summary (All financials)
| In millions, except per share items | Dec-31-02 | Dec-31-01 | Dec-31-00 |
| Revenues | 52,930.1 | 19,594.2 | 31,456.5 |
| Revenue growth | 170.1% | -37.7% | |
| Cost of goods sold | 27,361.6 | 12,533.4 | 25,711.1 |
| Gross profit | 25,568.5 | 7,060.8 | 5,745.3 |
| Gross margin | 48.3% | 36.0% | 18.3% |
| Selling, general and administrative | 7,754.2 | 5,909.2 | 9,966.3 |
| Research and development | 6,945.0 | 2,352.7 | 2,392.2 |
| EBIT | 10,869.4 | -1,201.1 | -6,613.1 |
| EBIT margin | 20.5% | -6.1% | -21.0% |
| Pre-tax income | 8,315.9 | -4,472.9 | -8,451.7 |
| Income taxes | 15,130.0 | 0.0 | 0.0 |
| Tax rate | 181.9% | 0.0% | 0.0% |
| Net income | 22,964.8 | -13,532.9 | -9,895.4 |
| Net margin | 43.4% | -69.1% | -31.5% |
| |
| Diluted EPS | $1.41 | ($1.57) | ($1.89) |
| Shares outstanding (diluted) | 16,322.2 | 8,629.4 | 5,232.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|